| 郭肖利,陈 琼,徐慧芳,等.2019年河南省肺癌流行特征及2010—2019年变化趋势分析[J].中国肿瘤,2024,33(5):358-365. |
| 2019年河南省肺癌流行特征及2010—2019年变化趋势分析 |
| Epidemiological Characteristics of Lung Cancer in Henan Province in 2019 and Its Trend from 2010 to 2019 |
| 投稿时间：2024-01-19 |
| DOI：10.11735/j.issn.1004-0242.2024.05.A004 |
|
 |
| 中文关键词: 肺癌 发病 死亡 趋势分析 河南 |
| 英文关键词:lung cancer incidence mortality trend analysis Henan |
| 基金项目:河南省重点研发专项（221111310200）；河南省医学科技攻关计划省部共建重大项目（SBGJ202001004）；河南省科技发展计划(232102310166，242102311158) |
|
| 摘要点击次数: 459 |
| 全文下载次数: 216 |
| 中文摘要: |
| 摘 要：［目的］ 分析2019年河南省肺癌发病与死亡情况及2010—2019年河南省肿瘤登记地区肺癌发病与死亡变化趋势。［方法］ 利用各肿瘤登记处上报且质控合格的肺癌发病与死亡资料，结合全省户籍人口数据，估算2019年河南省肺癌分城乡、性别、年龄组别肺癌发病/死亡例数、粗率、中标率、世标率、构成比、0~74岁累积率。采用Joinpoint Regression Program 4.8软件，计算2010—2019年河南省肿瘤登记地区肺癌中标发病率和死亡率的年度变化百分比（APC）和平均年度变化百分比（AAPC）。［结果］ 2019年河南省肺癌估计新发病例56 892例，粗发病率为51.95/10万，中标率和世标率分别为37.85/10万和38.06/10万，占全省所有恶性肿瘤新发病例的19.73%。河南省估计肺癌死亡病例43 625例，粗死亡率为39.83/10万，中标率和世标率分别为27.93/10万、28.11/10万，占全省全部恶性肿瘤死亡的26.35%。河南省2019年男性的发病率与死亡率均高于女性（男性：中标发病率为52.95/10万，中标死亡率为41.73/10万；女性：中标发病率为23.50/10万，中标死亡率为15.09/10万）。肺癌年龄别发病率与死亡率均在85岁及以上组达到高峰。2010—2019年间，河南省肿瘤登记地区的肺癌中标发病率和死亡率波动均呈平稳趋势，但城市地区男性在2014—2019年间肺癌中标发病率和死亡率每年分别下降4.6%和4.7%，农村地区男性中标死亡率每年下降4.7%。2010—2019年间，40~49岁年龄组男性、女性肺癌发病率与死亡率均呈现明显下降趋势。［结论］ 河南省肺癌发病与死亡水平依旧较高，疾病负担较重，后续应继续加强肺癌防控和筛查与早诊早治工作。 |
| 英文摘要: |
| Abstract：［Purpose］ To analyze the incidence and mortality of lung cancer in Henan Province in 2019 and the trends from 2010 to 2019 based on cancer registration data. ［Methods］ Using qualified data on the incidence and mortality of lung cancer and registered population data of Henan Province， the number of lung cancer cases/death was estimated and crude rate， age-standardized rates by Chinese standard population(ASIRC，ASMRC) and world standard population(ASIRW，ASMRW)， composition proportion， and cumulative rate of 0 to 74 years old in Henan Province in 2019 were calculated. The annual percentage change (APC) and average annual percentage change(AAPC) of lung cancer in Henan cancer registration areas from 2010 to 2019 were calculated using Joinpoint Regression Program 4.8 software. ［Results］ In 2019， there were 56 892 new cases of lung cancer in Henan Province， with a crude incidence rate of 51.95/105， ASIRC of 37.85/105， and ASMRC of 38.06/105. Lung cancer accounted for 19.73% of all newly diagnosed cancer cases. The number of deaths from lung cancer in Henan Province was 43 625， with a crude mortality rate of 39.83/105， ASIRW of 27.93/105， and ASMRW of 28.11/105. Lung cancer accounted for 26.35% of all deaths from cancers. In 2019， the incidence and mortality of men in Henan Province were higher than those of women(men： the ASIRC was 52.95/105， and the ASMRC was 41.73/105； women： the ASIRC was 23.50/105， and the ASMRC was 15.09/105). The incidence and mortality of lung cancer peaked in the group 85 years and above. From 2010 to 2019， the incidence and mortality rates of lung cancer showed a stable trend in the overall population. However， in urban areas， the incidence and mortality rates of lung cancer among men decreased by 4.6% and 4.7% per year， respectively， while in rural areas， the mortality rate among men decreased by 4.7% per year from 2014 to 2019. From 2010 to 2019， the incidence and mortality of lung cancer in men and women in the age group of 40 to 49 years showed a significant downward trend. ［Conclusion］ The overall burden of lung cancer remains significant in Henan Province， and efforts should be continued to strengthen prevention， screening， early diagnosis， and treatment. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |